MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC
Clinical trial NCT03881605 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03881605
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-08
- Primary completion
- 2025-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.